Summary
Overview
Work History
Education
Skills
Certification
Languages
Timeline
Publications
Generic

Radwa Yehia Mekky Youssef

Myrtle Beach,SC

Summary

South Carolina licensed pharmacist with PhD in Molecular Pharmacology and extensive academic research experience supported by multiple international peer reviewed publications. Full time Staff Pharmacist at Walgreens with strong experience in medication therapy management, immunization delivery, pharmacotherapy optimization, and patient counseling. Highly motivated to transition into hospital or clinical pharmacy practice to support medication safety, interdisciplinary collaboration, and evidence based therapeutic outcomes.

Overview

1
1
year of professional experience
1
1
Certification

Work History

Staff Pharmacist

Walgreens
Myrtle Beach, South Carolina, USA
01.2025 - Current
  • Verify and dispense prescriptions accurately in high volume pharmacy environment.
  • Conduct MTM sessions and identify drug therapy problems including interactions, duplications, and dosing issues.
  • Provide counseling for chronic diseases including diabetes, hypertension, dyslipidemia, and anticoagulation.
  • Administer adult immunizations and support preventive healthcare initiatives.
  • Collaborate with prescribers to optimize medication therapy and improve patient outcomes.
  • Supervise pharmacy technicians and ensure regulatory compliance and workflow efficiency.

Education

Ph.D. - Molecular Pharmacology And Toxicology

German University in Cairo
Cairo, Egypt
07-2014

Master of Science - Molecular Genetics

German University in Cairo
Cairo, Egypt
07-2010

Bachelor of Science - Pharmacy And Biotechnology

German University in Cairo
Cairo, Egypt
07-2009

Skills

  • Drug utilization review
  • Medication dispensing
  • Immunization administration
  • Patient consutation
  • Clinical Research skills
  • Grant paper writing
  • Scientific manuscript writing

Certification

  • Registered Pharmacist — South Carolina Board of Pharmacy (Active)
  • Immunization Certified Pharmacist
  • Basic Life Support (BLS) / CPR Certified
  • Medication Therapy Management (MTM) Experience

Languages

Arabic
Native or Bilingual
English
Full Professional
French
Elementary

Timeline

Staff Pharmacist

Walgreens
01.2025 - Current

Ph.D. - Molecular Pharmacology And Toxicology

German University in Cairo

Master of Science - Molecular Genetics

German University in Cairo

Bachelor of Science - Pharmacy And Biotechnology

German University in Cairo

Publications

  • Therapeutic potential of mesenchymal stem cells in cisplatin induced acute kidney injury. Archives of Medical Science (2024).
  • Vortioxetine ameliorates experimental autoimmune encephalomyelitis model via PI3K/Akt/CREB/BDNF cascade. European Journal of Pharmacology (2024).
  • Novel epigenetic strategy to block PD 1/PD L1 and CD155/TIGIT immune checkpoints in hepatocellular carcinoma. Translational Oncology (2024).
  • Pharmacogenomic and epigenomic approaches to IL 10 blockade in oncology. Expert Review of Molecular Medicine (2024).
  • Photoresponsive liposomes in cancer chemotherapy and immunotherapy. ACS Omega (2023).
  • MALAT1 immunomodulatory lncRNA in triple negative breast cancer. Translational Oncology (2023).
  • Risk benefit of fat soluble vitamin supplementation in COVID 19 autoimmune and cancer patients. Life (Basel) (2022).
  • EGCG and miR 548m reduce HCV entry via CD81 repression. Archives of Virology (2019).
  • MiR 148a and miR 30a limit HCV dependent lipid droplet suppression. Journal of Medical Virology (2017).
  • Contradicting roles of miR 182 in NK cells and hepatocytes in HCV. Immunology Letters (2016).
  • Repressing PU.1 by miR 29a
  • Diminishes NK cytolytic effect in HCV. Human Immunology (2015).
  • Epigenetic modulation of lipid droplet protein TIP47 in HCV models. FEBS Letters (2015).
  • Expression signature of microRNA 155 in HCV genotype 4 infection. Biomedical Reports (2015).
  • Predictive prognostic role of miR 181a in genotype 4 HCV patients. Biomedical Reports (2014).
  • MiR 194 as hepatocyte gatekeeper hindering HCV entry via CD81 targeting. Journal of Infection (2015).
  • Sex hormones and HCV: an unresolved mystery. Expert Review of Gastroenterology & Hepatology (2013).
  • Estrogen related MXA transcriptional variation in HCV infected patients. Translational Research (2012).
Radwa Yehia Mekky Youssef